Kavita M Dhodapkar, Sharon Castellino, Shivani Kapadia, Maryam I Azeem, Ava Horvat, Taylor Lawrence, Deborah DeRyckere, Madhav V Dhodapkar
{"title":"Immune-aging at diagnosis determines T-cell recovery in childhood leukemia survivors.","authors":"Kavita M Dhodapkar, Sharon Castellino, Shivani Kapadia, Maryam I Azeem, Ava Horvat, Taylor Lawrence, Deborah DeRyckere, Madhav V Dhodapkar","doi":"10.1038/s41514-025-00233-0","DOIUrl":null,"url":null,"abstract":"<p><p>We show that T cells in survivors of childhood leukemia exhibit distinct profiles dominated by aging-associated changes and consistent with premature immune aging. Immune profiles during survivorship in biospecimens (n = 251) from uniformly-treated children with B-acute lymphoblastic leukemia recapitulate heterogeneity at diagnosis in individual patients and correlate with genetic-risk subtypes. These data suggest that pre-therapy immune aging may determine variance in immune status during survivorship.</p>","PeriodicalId":94160,"journal":{"name":"npj aging","volume":"11 1","pages":"39"},"PeriodicalIF":4.1000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12102316/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"npj aging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/s41514-025-00233-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
We show that T cells in survivors of childhood leukemia exhibit distinct profiles dominated by aging-associated changes and consistent with premature immune aging. Immune profiles during survivorship in biospecimens (n = 251) from uniformly-treated children with B-acute lymphoblastic leukemia recapitulate heterogeneity at diagnosis in individual patients and correlate with genetic-risk subtypes. These data suggest that pre-therapy immune aging may determine variance in immune status during survivorship.